ORTEXORTEX News
Tracking KSS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
KS
Trader NoteKSS

Kohl's shorts keep covering but options traders grow more cautious

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 18:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

KSS is a stock where the bears are slowly retreating and the options market is starting to notice.

Short covering has continued through this week, and the trend is now well-established. Short interest has fallen to 26.6% of free float, down from 27.6% a week ago and from a plateau above 32 million shares in late September. Bears have trimmed roughly 3 million shares over the past month, using the stock's 31% one-month rally to close positions rather than press them. The ORTEX short score has eased further to 65.5, down from 68.3 at the start of last week and from a peak near 69.9 in late September. That is a consistent, week-by-week reduction in bearish conviction, not a single-session blip. The borrow market is not adding pressure. Availability has actually loosened further to 349%, up 32% on the week, meaning there are more than three shares available for every one already lent. Cost to borrow is running at 0.45%, barely changed. There is no squeeze dynamic here: shorts are covering because the stock is up, not because they are being forced out.

Options positioning tells a different story from the short-covering trend. Put demand has ticked up to a put/call ratio of 1.10, nearly 1.8 standard deviations above the 20-day average of 1.05. That is not a panic reading, but it is the highest level in several weeks and sits well above the mid-1.00 range that characterised most of September. With November earnings now 35 days away, options traders appear to be buying some protection into the rally rather than chasing the upside. The 52-week high on the PCR is 1.49, so there is room to move further in either direction, but the drift higher is consistent with a market that is less certain about the stock at $21.74 than it was when it was trading in the low-to-mid teens.

The Street remains broadly sceptical. JP Morgan holds an Underweight with a $17 target. Morgan Stanley reinstated at Underweight with a $15 target. Bank of America has an Underperform. The mean analyst price target sits at $18.63, below where the stock is trading today. Citi is the lone Buy with a $22 target, effectively at the current price. The factor picture adds nuance: the 90-day EPS momentum score ranks in the 81st percentile, suggesting earnings estimates have been revised up over a longer period, while the 30-day EPS momentum reads in just the 8th percentile, meaning that trend has stalled or reversed more recently. The short score rank, at the 8th percentile, confirms that by the standards of the broader market, KSS remains one of the most heavily shorted names. The price-to-book multiple has expanded to 0.56, up about 0.11 over the past month, reflecting the rally but still a fraction of book value.

On the ownership side, BlackRock is the most notable institutional holder, having built to 18.5% of shares as of September 30, adding 1.7 million shares in the period. Dimensional Fund Advisors raised its stake to 6.1% in the same quarter, adding 1.35 million shares. No 13D activist is on the register, and all major holders are filing passive 13G schedules. The only insider activity of note was a series of compensation-related awards to senior officers on October 15, alongside two planned sales by the Chief Legal Officer totalling about $504,000 under a pre-arranged 10b5-1 plan. Planned sales carry far less signal than discretionary ones. Net insider value over 90 days is negative $1.26 million, but that figure is dominated by the pre-planned sales rather than open-market conviction.

Wikipedia traffic for KSS is running above its own 90-day history, with a z-score of 1.43 as of October 13, reflecting retail investor attention that has risen with the stock's recovery. This is a colour indicator rather than a financial signal, but it does confirm that the rally has drawn some outside interest.

The next scheduled earnings date is November 25. With short interest still above a quarter of the float, options protection building modestly, and analyst targets sitting mostly below the current price, the question heading into that print is whether the covering trend has further to run or whether bears decide the stock has reached fair value and begin to rebuild.

Stocks in this article

See the live data behind this article on ORTEX.

Open KSS on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:38
Data as of
21 Oct 2026, 18:31
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.